Values First Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.77M | Sell |
|
|||||
|
2025
Q2 | $1.29M | Sell |
|
|||||
|
2025
Q1 | $2.19M | Sell |
|
|||||
|
2024
Q4 | $2.12M | Buy |
|
|||||
|
2024
Q3 | $2.42M | Buy |
|
|||||
|
2024
Q2 | $1.84M | Sell |
|
|||||
|
2024
Q1 | $1.16M | Buy |
|
|||||
|
2023
Q4 | $1.34M | Buy |
|
|||||
|
2023
Q3 | $1.15M | Sell |
|
|||||
|
2023
Q2 | $1.25M | Buy |
|
|||||
|
2023
Q1 | $1.28M | Buy |
|
|||||
|
2022
Q4 | $1.5M | Buy |
|
|||||
|
2022
Q3 | $1.25M | Buy |
|
|||||
|
2022
Q2 | $885K | Sell |
|
|||||
|
2022
Q1 | $1.06M | Buy |
|
|||||
|
2021
Q4 | $1.04M | Sell |
|
|||||
|
2021
Q3 | $1.23M | Buy |
|
|||||
|
2021
Q2 | $1.07M | Sell |
|
|||||
|
2021
Q1 | $908K | Buy |
|
|||||
|
2020
Q4 | $823K | Sell |
|
|||||
|
2020
Q3 | $951K | Buy |
|
|||||
|
2020
Q2 | $919K | Sell |
|
|||||
|
2020
Q1 | $691K | Buy |
|
|||||
|
2019
Q4 | $689K | Buy |
|